French industrial fermentation company applying yeast and microalgae expertise to produce bioactive ingredients for food, feed, and cosmetics markets.
Lallemand SAS is the French subsidiary of the global Lallemand group — a privately held industrial company specializing in yeast and fermentation science, with applications spanning food, beverages, animal nutrition, and health. In EU research, they contribute industrial expertise and production know-how: in YEASTDOC they served as an industry host for doctoral training in yeast genetics and cell factory engineering, and in SCALE they brought fermentation and application expertise to a consortium developing microalgae-derived bioactive compounds for commercial markets. Their core value in research consortia is bridging the gap between lab-scale biology and real-world product formulation — they know what it takes to turn a promising microorganism into an ingredient that works in feed, food, cosmetics, or supplements.
YEASTDOC (2017–2022) was a dedicated MSCA doctoral training programme in yeast biotechnology where Lallemand participated as an industry partner, contributing expertise in yeast genetics and food/beverage applications.
SCALE (2021–2025) targets production of high-value compounds from microalgae using photobioreactors for application in feed, food, cosmetics, and food supplements — Lallemand is a funded participant with EUR 194,335.
Both projects share a common thread of translating biological production (yeast or algae) into commercially relevant product categories across food, beverage, feed, and cosmetic sectors.
In their earliest H2020 engagement (YEASTDOC, 2017), Lallemand's focus was firmly on yeast — genetics, cell factory design, and fermentation for food and beverages, reflecting their core industrial identity. By 2021, with SCALE, their emphasis shifted to microalgae as a biological production platform, with photobioreactor systems and high-value compound extraction for a broader range of applications including cosmetics and supplements. This shift suggests a deliberate move to expand beyond traditional yeast fermentation into the emerging algae-based bioeconomy, while keeping the same commercial logic: produce ingredients efficiently and at scale for industrial end-markets.
Lallemand is expanding from its yeast/fermentation base into algae-based production systems, indicating a strategic bet on the blue bioeconomy as a source of high-value ingredients for food, feed, and personal care markets.
Lallemand has not led any H2020 project — they consistently join as a partner or third party, which is typical for large industrial companies that contribute application expertise and real-world validation rather than driving research agendas. Their 25 consortium partners across 11 countries, accumulated across just two projects, suggest they work in broad, multi-partner research consortia rather than tight bilateral collaborations. Working with them likely means gaining access to industrial formulation knowledge and potential routes to market, in exchange for including them as an application or validation partner.
Lallemand SAS has built connections with 25 unique consortium partners across 11 countries through just two projects — a relatively wide network footprint for minimal project participation, reflecting their membership in large multi-partner consortia such as MSCA training networks and innovation actions.
Among food and fermentation companies in France, Lallemand stands out as an industrial partner that spans both classical microbial fermentation (yeast) and next-generation biological production (microalgae) — a combination that is valuable for consortia needing both deep fermentation know-how and credible routes to commercial application. They are not a research institute producing papers, but a manufacturing-oriented company whose involvement signals that a project's outputs are being taken seriously by an industry player with actual production capacity and market access. For consortium builders, their participation adds industrial credibility and real application context that purely academic partners cannot provide.
